Skip to main content

Table 2 Sociodemographic and medical characteristics of the sample (n = 577)

From: Psychometric properties of the fatigue questionnaire EORTC QLQ-FA12 and proposal of a cut-off value for young adults with cancer

Sociodemographic characteristics

N (%)

Sex

577 (100.0)

 Male

153 (26.5)

 Female

424 (73.5)

Age at Interview (M = 30.3, SD = 6.1)

577 (100.0)

 18 to < 26 years

164 (28.4)

 26 to < 42 years

413 (71.6)

Education

573 (100.0)

 No educational degree/student

6 (1.0)

 Basic educational degree (< 10 years)

37 (6.5)

 Secondary educational degree (10 years)

190 (33.2)

 Highschool degree (> 10 years)

340 (59.3)

Medical characteristics

N (%)

Age at Diagnosis (M = 29.3, SD = 6.1)

577 (100.0)

 18 to < 26 years

184 (31.9)

 26 to < 40 years

393 (68.1)

Time since Diagnosis (M = 11.9, SD = 8.0)

577 (100.0)

 up to 2 months

8 (1.4)

 > 2 to 4 months

38 (6.6)

 > 4 to 6 months

69 (12.0)

 > 6 to 12 months

269 (46.6)

 > 12 to 24 months

145 (25.1)

 more than 24 months

48 (8.3)

Diagnosis

577 (100.0)

 Breast Cancer [C50]

150 (26.0)

 Hodgkin Lymphoma [C81]

99 (17.2)

 Gynecological Cancer [C51-C57]

51 (8.8)

 Testicular Cancer [C62]

50 (8.7)

 Non-Hodgkin Lymphoma [C82-C90]

42 (7.3)

 Haematological Cancer [C91-C95]

38 (6.6)

 Thyroid Cancer [C73]

32 (5.5)

 Gastrointestinal Cancer [C15-C26]

29 (5.0)

 Sarcoma [C40-C41, C46-C49]

26 (4.5)

 Melanoma [C43]

19 (3.3)

 Other C, D00-D48 and Carcinoma in situ

41 (7.1)

Therapiesa, b

577 (100.0)

 Chemotherapyc

443 (76.8)

 Radiotherapyd

264 (45.8)

 Surgery

427 (74.0)

 Neither chemo- nor radiotherapy

85 (14.7)

  1. amultiple answers possible; b Due to further validation of data there are deviations to the baseline medical therapies published in the study protocol [49].; c including Radio-Chemotherapy; d including nuclear therapies and Radio-Chemotherapy